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Abstract
Background:  To generate a replication-competent retrovirus that could be conditionally
inactivated, we flanked the viral genes of the Akv murine leukemia virus with LoxP sites. This
provirus can delete its envelope gene by LoxP/Cre mediated recombination and thereby allow
superinfection of Cre recombinase expressing cells.
Results: In our studies, the virus repeatedly infected the cell and delivered multiple copies of the
viral genome to the host genome; the superinfected cells expressed a viral transgene on average
twenty times more than non-superinfected cells. The insertion of multiple LoxP sites into the
cellular genome also led to genomic deletions, as demonstrated by comparative genome
hybridization.
Conclusion:  We envision that this technology may be particularly valuable for delivering
transgenes and/or causing deletions.
Background
Resistance to superinfection by receptor interference has
been established for several groups of retroviruses when
the infected cell produces the viral envelope protein [1-7].
In addition to being a component of burgeoning viruses,
the envelope is also believed to bind to the cellular recep-
tor of the virus, either intracellularly or at the cell mem-
brane. This interaction prevents adequate surface display
of the receptor, without which other retroviruses depend-
ent on the same receptor cannot enter and infect the cell
[8-10].
Resistance to superinfection may present an obstacle to
applications of retroviral gene technology where multiple
hits are required. Such applications include delivery of
transgenes in multiple copies and introduction of multi-
ple target sites for DNA recombinases to create deletions
or rearrangements of host cell DNA. While gammaretrovi-
ral packaging cell lines can be manipulated to generate a
high multiplicity of infection in cell culture [11,12], it
may be useful, especially for studies in animal models, to
have a retrovirus that circumvents superinfection barriers
without such lines.
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Akv is a well-characterized ecotropic murine leukemia
virus (MLV) [13-18]; the cell surface receptor for Akv and
other ecotropic MLVs is a cationic amino acid transporter,
CAT-1 [19]. Among various designs of replication-compe-
tent vectors based upon gammaretroviruses, the most sta-
ble transgene maintenance has been achieved by inserting
the gene with an internal ribosomal entry site (IRES) into
the U3 region or 3'UTR [20,21]. Here we utilize an Akv
virus that delivers a transgene located in the U3 region.
Because we flanked the structural genes of the virus with
LoxP sites, the virus can delete its envelope gene and thus
ought to be able to permit superinfection of cells that
express Cre recombinase. Furthermore, because the virus
can randomly distribute LoxP sites over the host genome,
we investigated the potential of the virus for deletional
mutagenesis.
Results and Discussion
Design of a replication competent superinfecting retroviral 
vector
The objective of this study was to engineer an Akv-based
retroviral vector capable of superinfection, and to assess
its potential for both transgene overexpression and dele-
tional mutagenesis. Because we wanted the vector to
undergo multiple rounds of replication, in particular to
allow efficient delivery in animal model settings, we based
our design upon a virus with the full set of genes needed
for replication. To easily monitor infection and transgene
expression by flow cytometry, we inserted the Enhanced
Yellow Fluorescent Protein (EYFP) downstream of an
IRES into the U3 region of the LTR (Fig. 1). To allow
superinfection, we flanked the envelope gene with two
LoxP sites so that it could be excised by Cre recombinase.
The exact positioning of the LoxP sites (Fig. 1) was based
upon the following considerations. If the LoxP site were to
be placed in the LTR [22], Cre mediated deletion of the
proviral LoxP fragment would result in a solo LTR, from
which transgene expression would be difficult to achieve.
We therefore inserted the downstream LoxP site at a posi-
tion 9 bp after the TAA stop codon of env, just before the
LTR. Because of the overlapping regions of gag-pol and env,
it would be complicated to engineer the upstream LoxP
site into the viral genome immediately in front of the cod-
ing sequence of env without compromising proper expres-
sion of viral proteins. We therefore placed the second
LoxP site upstream of gag, but downstream of the major
cis-elements for RNA packaging [23]. For convenience of
construction, we chose position 413 of the viral RNA, 232
nt upstream of the ATG start codon of gag.
Normal NIH/3T3 cells infected with Akv-Y (virus contain-
ing EYFP, but no LoxP sites) and Akv-2XY (virus contain-
ing EYFP and two LoxP sites) are expected to be resistant
to superinfection, since infected cells constantly produce
envelope protein (Fig. 2). Consistent with this notion, the
intensity of EYFP fluorescence of the infected cells was
unchanged over a period of more than two months (data
not shown).
The viral titer from PhoenixEco cells, a retroviral packag-
ing line, used to initially infect the NIH/3T3 cells corre-
sponded to a multiplicity of infection of <0.05. Because
Akv-Y and Akv-2XY were fully competent viruses, the
NIH/3T3 population infected by PhoenixEco-generated
viral supernatant was able to propagate the infection to
the rest of the culture. Because of the low multiplicity of
infection and the stable transgene expression level over
time, the superinfection resistant population can be
assumed to contain close to just one active copy of the
EYFP gene per cell. Therefore, the EYFP fluorescence from
NIH/3T3 cells infected by Akv-Y or Akv-2XY, respectively,
served as a reference for quantitative comparison in this
study.
Cre-mediated inactivation of env production
Clone GC4 is an NIH/3T3-derived cell clone transduced
with a replication-defective retroviral vector that encodes
a fusion protein consisting of EGFP and Cre recombinase
(see Materials and Methods). GC4 cells were infected by
adding supernatant containing the complete retroviruses,
Akv-Y or Akv-2XY. After 10 days in culture, the infection
by Akv-Y had spread to nearly all GC4 cells. This can be
deduced from the fact that almost all cells expressed viral
envelope protein on the surface and EYFP (Fig. 3a). Since
the EYFP intensity of the Akv-Y infected GC4 population
did not increase appreciably over time, this indicated that
the GC4 cells resisted superinfection.
In contrast, after 10 days only 6.8 % of the GC4 culture
infected with Akv-2XY expressed EYFP (Fig. 3b; Table 1).
Assuming a Poisson distribution of infection, the low
multiplicity of infection allowed us to calculate that the
infected population contained one active copy of the
EYFP gene per cell (Table 1). The lack of surface envelope
protein by this same population (Fig. 3b) suggested that
GFP-Cre had excised the envelope gene, and thus had
inactivated the virus' ability to replicate. Because almost
no cells on days 5 and 10 expressed surface envelope, it is
likely that the Cre-mediated deletion occurred quickly
after reverse transcription and rendered the virus incapa-
ble of replication. However, after 16 days some envelope
expressing cells were detected, suggesting that a mutant,
either viral or cellular, had emerged (Fig. 3b).
Infection by mixed culture
Because our LoxP containing virus was so quickly made
replication-incompetent in Cre recombinase active cells,
we used infected NIH/3T3 cells ("feeder cells") as a steady
generator of viruses and co-cultured them with initially
uninfected GC4 cells ("host cells"). Because they fluoresceRetrovirology 2004, 1 http://www.retrovirology.com/content/1/1/5
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green, the host cells can be distinguished from the feeder
cells by flow cytometry.
The cultures were seeded with 10% NIH/3T3 cells stably
infected with Akv-Y or Akv-2XY and 90% GC4 cells. After
10 days, the GC4 cells were almost completely infected by
Akv-Y, as shown by envelope and EYFP expression (Fig.
4a). In this co-culture, the stable EYFP fluorescence over
time, and the near equal EYFP fluorescence between the
host and feeder populations demonstrated superinfection
resistance. In contrast, the EYFP expression of GC4 cells
infected with Akv-2XY increased over a period of 16 days,
after which the average EYFP intensity was forty-three
times greater than in the feeder cells (Fig. 4b; Table 1).
This demonstrated that Akv-2XY was able to superinfect
cells with Cre recombinase activity. We estimated that
Akv constructs Figure 1
Akv constructs. (a) LoxP sites in Akv-2XY were inserted between the 5'LTR and gag and between the env and the 3'LTR. (b) 
The Akv-Y provirus contained IRES-EYFP in the U3 region of the LTR. (c) The Akv-2XY provirus contained IRES-EYFP and two 
LoxP sites flanking the Akv structural genes. (d) Cre-mediated recombination of the LoxP sites in Akv-2XY results in deletion 
of the viral genes. Each of the proviruses contained two BsrG1 sites, B. The sizes (kb) of DNA segments generated by BsrG1 
are above each construct.
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after 16 days there were, on average, 20 or more actively
expressed provirus copies per cell (Table 1). We also noted
that, unlike in the supernatant infection experiments,
there was some envelope protein present on the surface of
the GC4 cells. However, the Env expression was consider-
ably lower than that of the feeder cells. If indeed the enve-
lope gene was deleted from provirus and not produced
from the host cell, the envelope protein might arise from
"shedded" Env-protein or particles bound or fused to the
cell membrane [24]. This would likely require the high
concentrations of virus maintained by the mixed culture.
One advantage of using GFP-Cre recombinase fusion pro-
tein was that we could monitor the population dynamics
of the feeder and host cell populations using flow cytom-
etry. While the Akv-Y mixed culture essentially main-
tained the initial 10% NIH/3T3 and 90% GC4 cell
distribution, in the Akv-2XY mixed culture, the GC4 frac-
tion steadily decreased and after 16 days consisted of only
2.8% of the culture. The multiple integrations of the Akv-
2XY provirus apparently bestowed a considerable growth
disadvantage. This disadvantage could be due to the bur-
den of the additional proviruses. In addition, when two
LoxP containing proviruses integrate on the same chro-
mosome, a deletion of genomic DNA from the host cell
can occur (see below). These deletions could kill or slow
the growth of a cell. Translocations, though reportedly
infrequent in Cre-expressing cells with multiple LoxP sites
[25], and inversions of genomic DNA may also adversely
affect the growth of the host GC4 cells.
Analysis of subclones
After either 10 or 16 days in the mixed culture, infected
cells were subcloned by single cell fluorescence activated
cell sorting (FACS). The subclones were expanded and
then analyzed by flow cytometry (Fig. 5). The fluorescence
intensity was correlated to that of the unsubcloned cells
that were presumed to have on average one expressed
EYFP gene per cell (Table 2).
After 39 days in culture (10 or 16 days in the mixed cul-
ture followed by 29 or 23 days as a subcloned culture)
three of the Akv-Y subclones, AYGC.2A2 (Fig. 5; Table 2),
AYGC.2A3 and AYGC.2C3 (Table 2), had EYFP intensities
Flow cytometry analysis of control cells, demonstrating GFP-Cre, EYFP, and surface envelope (Env) expression Figure 2
Flow cytometry analysis of control cells, demonstrating GFP-Cre, EYFP, and surface envelope (Env) expression. These control 
cells consist of NIH/3T3 cells uninfected or infected with AkvY or Akv2XY and GC4, a GFP-Cre expressing NIH/3T3 line 
expanded from a single clone.
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Flow cytometry analysis of GC4 cells infected by virus containing supernatant to measure GFP-Cre, EYFP, and surface enve- lope (Env) expression Figure 3
Flow cytometry analysis of GC4 cells infected by virus containing supernatant to measure GFP-Cre, EYFP, and surface enve-
lope (Env) expression. Infection by (a) Akv-Y and (b) Akv-2XY; shown are days 5, 10, and 16. Y-axis, fluorescence intensity on 
a logarithmic scale of EYFP and Env, respectively. X-axis, fluorescence intensity of GFP-Cre.
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corresponding to the reference population of one EYFP
provirus expressed per cell. One Akv-Y subclone,
AYGC.3B2, from a cell population with high EYFP fluores-
cence (Region C of Fig. 5a), expressed EYFP with an inten-
sity two to three times higher (Table 2). Each of the Akv-Y
subclones expressed surface envelope protein at a high
level, comparable to the unsubcloned, infected NIH/3T3
cells. This indicated that it was the host cell that expressed
the envelope gene, directed by the integrated provirus.
In contrast, none of the Akv-2XY subclones had envelope
on the cell surface, indicating that the envelope gene
indeed had been excised by Cre/LoxP recombination (for
example, clones 2B1 and 3B8 in Fig. 5). This also supports
the assertion that the low amount of envelope observed
on GC4 cells in the mixed culture was not due to envelope
gene transcription by the provirus [24]. After 39 days in
culture, the average fluorescence intensity of EYFP from
the Akv-2XY subclones was 30 to 50 times greater than the
unsubcloned, infected NIH/3T3 population. We esti-
mated a range of 18–29 expressed copies of the transgene
in the subclones (Table 2).
Analysis of integration sites
Because each cell of a subclone culture should have the
same integration site, the sites of various clones could be
analyzed by Southern blotting (Fig. 6a). Genomic DNA
digested with BsrG1 was examined using EYFP as a probe.
The 9.6 kb bands from the Akv-Y subclones represent the
BsrG1 fragment of the original provirus containing the 3'
copy of the EYFP gene (Fig. 1b). After Cre-recombinase-
mediated deletion in the Akv-2XY subclones, the 9.6 kb
fragment is converted into the 2.3 kb BsrG1 fragment of
the recombined provirus, which still contains the 3' copy
of the EYFP gene (Fig. 1d). Because equal amounts of
DNA were loaded into each lane, the greater intensity of
the 2.3 kb bands shows that the Akv-2XY subclones con-
tained a greater number of proviruses, providing further
evidence that the virus is capable of superinfection. Since
bands smaller and larger than 2.3 kb had lower intensities
than the 2.3 kb bands, the intensity difference is not likely
due to incomplete transfer to the membrane. It is possible
that the 2.3 and 9.6 kb bands also represent unintegrated
provirus, as unintegrated DNA may be found in superin-
fected cells [26,27]. However, we believe this to be less
likely, since such complexes would have to survive for
many cell generations (cells were grown for over 2 months
before the Southern blots were performed) after we sub-
cloned the cells (after subcloning, cells were no longer
being infected with new virus).
The other bands on the gel represent the fragment con-
taining part of the 5' LTR and the adjacent host genomic
DNA, with each band marking a unique integration site.
Due to their abundance (>17) the unique bands from the
Table 1: Proviral expression and estimated copy numbers in infected GC4 cell populations.
Virus Infection time (days) GFP-Cre+ (%) GFP-Cre+ EYFP+ (%) GFP-Cre+ EYFP- (%) Ratio of 
intensitiesa 
Est. # of expressed 
copies
(GC4 EYFP)/(NIH/
3T3 EYFP)
(GC4 EYFP)/(one 
expressed EYFP)
Akv-Y supernatant 5 99.2 78.7 20.5 0.5 1b
Akv-Y supernatant 10 99.6 95.7 3.9 0.9 1b
Akv-Y supernatant 16 99.1 95.7 3.5 1.2 1b
Akv-2XY supernatant 5 99.1 5.4 93.7 1.8
Akv-2XY supernatant 10 99.6 6.8 92.8 1.7 1c
Akv-2XY supernatant 16 99.4 12.7 86.8 1.6
Akv-Y mixed culture 5 88.5 82.5 6.0 0.9 1b
Akv-Y mixed culture 10 93.2 91.8 1.4 0.9 1b
Akv-Y mixed culture 16 92.6 91.4 1.2 1.1 1b
Akv-2XY mixed culture 5 69.3 46.7 22.7 3.9 2d
Akv-2XY mixed culture 10 46.4 45.5 0.9 12.8 8d
Akv-2XY mixed culture 16 2.8 2.8 0.0 43.1 20d
a For a given virus, the ratio was calculated with fluorescence intensities of that virus to account for differences not related to copy number (see 
Materials and Methods). b One expressed EYFP gene based on unsubcloned NIH/3T3 EYFP fluorescence intensity. c One expressed EYFP gene 
based on the Poisson distribution calculation, using the EYFP- value of non-infected cells. d One expressed EYFP gene based on single expressed 
EYFP fluorescence intensity from supernatant infected culture.Retrovirology 2004, 1 http://www.retrovirology.com/content/1/1/5
Page 7 of 14
(page number not for citation purposes)
Flow cytometry analysis of GC4 cells infected by virus-producing NIH/3T3 cells in a mixed culture Figure 4
Flow cytometry analysis of GC4 cells infected by virus-producing NIH/3T3 cells in a mixed culture. GFP-Cre, EYFP, and surface 
envelope (Env) expression were measured. The GC4 populations were GFP-Cre+ and virus producing NIH/3T3 were GFP-
Cre-. Infection by (a) Akv-Y and (b) Akv-2XY was monitored over 16 days. Subclones were isolated from boxed regions A-G 
by single-cell sorting.
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Flow cytometry analysis of clones of GC4 infected by Akv-Y and Akv-2XY Figure 5
Flow cytometry analysis of clones of GC4 infected by Akv-Y and Akv-2XY. The profile of AYGC.2A2 was representative of all 
Akv-Y infected GC4 clones, expressing Env and EYFP. The profile of A2XYGC.2B1 was representative of all Akv-2XY infected 
GC4 clones, except A2XYGC.3B8, in that they expressed high EYFP levels and GFP-Cre but no Env. Of all the clones isolated 
from the Akv-2XY infected GC4 cells, A2XYGC.3B8 did not demonstrate GFP-Cre fluorescence comparable to the GC4 
mother cell line or the other clones.
Table 2: Proviral expression and estimated copy numbers in GC4 subclones
Subclone Virus region sortedb Ratio of intensities Est. # of expressed copiesa 
(GC4 EYFP)/(NIH/3T3 EYFP) (GC4 EYFP)/(One expressed EYFP)
AYGC.2A2 Akv-Y A 0.6 1
AYGC.2A3 Akv-Y A 1.0 1
AYGC.2C3 Akv-Y B 0.6 1
AYGC.3B2 Akv-Y C 2.5 2–3
A2XYGC.2A2 Akv-2XY D 49.8 29
A2XYGC.2B1 Akv-2XY E 45.7 27
A2XYGC.2C1 Akv-2XY F 34.9 21
A2XYGC.3B1 Akv-2XY G 43.5 26
A2XYGC.3B3 Akv-2XY G 30.1 18
A2XYGC.3B8 Akv-2XY G 42.8 25
a For the Akv-2XY virus, this value accounts for the difference in EYFP intensity between the unrecombined and recombined provirus. b Sorted 
regions boxed on Fig. 4.
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Akv-2XY subclones were not easily counted. However,
there are more bands present in the clones infected with
the LoxP containing virus than with the virus without
LoxP.
Consistent with its high EYFP intensity (Table 2), sub-
clone AYGC.3B2 showed two, or perhaps three, unique
bands on the Southern blot, possibly representing the
number of expressed EYFP genes. In Akv-Y subclones
AYGC.2A2, AYGC.2A3, and AYGC.2C3, the Southern blot
Southern analysis of subclones Figure 6
Southern analysis of subclones. Cellular DNA digested with BsrG1 and visualized using an (a) EYFP and (b) Cre probe. Lanes 
contained DNA (8 µg/lane) from clones (1) AYGC.2A2, (2) AYGC.2A3, (3) AYGC.2C3, (4) AYGC.3B2, (5) A2XYGC.2A2, (6) 
A2XYGC.2B1, (7) A2XYGC.2C1, (8) A2XYGC.3B1, (9) A2XYGC.3B3, and (10) A2XYGC.3B8, and cell lines (11) GC4 and 
(12) NIH/3T3. (*) DNA size marker, 1-kb ladder. When more DNA (15 µg/lane) was applied, more EYFP-probed bands can be 
discerned (not shown). The Cre probe hybridizes to the vector-genomic DNA junction.
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showed that there were more than one integration site,
but their EYFP fluorescence intensities suggested that
these subclones contained only one active EYFP gene per
cell. This discrepancy might be due to a position effect on
expression [28], thus resulting in a different gene copy
prediction, or be due to silencing of retroviral genes
[29,30], including the envelope gene.
Evidence for deletions generated in the cellular DNA
By delivering LoxP sites to a genome, the LoxP virus may
create large gene deletions, translocations, and inversions.
Because the superinfecting retrovirus is able to deliver
numerous copies of LoxP, these mutations can be created
proficiently. The high multiplicity of infection will favor
the integration of two LoxP sites (of the same directional
orientation) on the same chromosome and this would
result in gene deletion. Because large deletions of DNA
(i.e. several megabases) can occur without lethal effects
[25,31,32] the superinfecting retrovirus can be used to tag
genes where a phenotype results from gene inactivation,
e.g. a tumor suppressor gene. Indeed, we found by flow
cytometry that one Akv-2XY infected clone, A2XYGC.3B8,
lacked GFP-Cre, yet EYFP expression indicated multiple
expressed proviral copies (Fig. 5). This may imply that the
deletion of the DNA segment containing Cre recombinase
must have occurred after deletion of the proviral segments
containing the viral structural genes. Consistent with the
notion that there was deletion leading to the absence of
expression, rather than silencing of the gene, on a South-
ern blot hybridized with a Cre recombinase probe, there
was no band detected in the subclone (Fig. 6b, lane 10),
while a 1.7 kb band was visible in other cells of GC4 cell
lineage (Fig. 6b). Because superinfection did lead to a
growth disadvantage before subcloning, it is possible that
cells inactivating the GFP-Cre gene, and thus stopping the
superinfection process, might be selected for and enriched
in the culture. It is also possible that whole chromosomal
deletion led to loss of the GFP-Cre; this may or may not
have been mediated by LoxP recombination.
We further searched for deletions in these cell lines using
array-based comparative genome hybridization (ACGH)
[33,34]. ACGH can scan an entire genome for copy
number changes including single copy losses and gains.
The resolution of ACGH is limited only by the genomic
spacing of the clones that are present on the arrays. For the
experiments reported here we used an average resolution
of 1 clone per 4–5 Mb across all chromosomes, with some
regions of the genome covered at much higher resolution.
Of the six Akv-2XY clones analyzed, four contained intra-
chromosomal deletions large enough to be detected with
our arrays (Fig. 7), while none of the four Akv-Y clones
contained evidence for such deletions (not shown here;
array CGH data from all cell lines is available at http://
cc.ucsf.edu/gray/public). In addition to the normal, con-
ventional genome comparison (Fig. 7, left side), deletions
were confirmed by performing hybridizations in a reverse
orientation (Fig. 7, right side) such that deletions
appeared as gains. The sizes of the deletions varied. Since
one of the deletions occurred in a region of the genome
for which we had a high density of arrayed clones, we
clearly defined it as an 18 Mb deletion (Fig. 7a). Other
deletions were less well defined but ranged in sizes from
46–100 Mb (Fig. 7b), 6–30 Mb (Fig. 7c), and 0.2–21 Mb
(Fig. 7d) – the limit of resolution for the arrays used here.
In addition to the intrachromosomal deletions, whole
chromosome losses were detected relative to the mother
cell line GC4. These whole chromosome losses likely
occurred during propagation of the polyploid GC4 cell
line in vitro and are not likely due to a Cre mediated event.
Conclusion
Gene delivery by LoxP viruses
In our experiments the Cre recombinase activity was so
high that the envelope gene was excised soon after infec-
tion. As a result, the integrated proviruses not only
allowed the host cell to be reinfected, but also abolished
viral replication. In cases where extinguishing the virus is
desired, this is clearly advantageous. Alternatively, it is
possible that there exists a level of Cre activity such that
some virus is still generated before recombination while
superinfectibility is maintained. Under such
circumstances the virus would be both replication compe-
tent and capable of superinfection. Furthermore, in a
given transgenic mouse strain, usually not all cells express
Cre and such cells can serve as a reservoir for virus produc-
tion. In another modification of the virus, it may be pos-
sible to engineer a superinfecting virus to also deliver Cre.
In this case, recombinase producing cells or organisms
would not be required for superinfection.
The LoxP virus could have applications when a high
number of integrations of a transgene, provirus, or LoxP
site are desired. As done in this study, cell lines expressing
multiple copies of a transgene can be created by infection
with the engineered virus. A superinfecting virus might
also be useful in delivering a transgene to animals – for
example, to chickens where exogenous protein can be pro-
duced in eggs [35,36] and to mammals where exogenous
protein can be produced in milk [37,38]. The virus may be
useful in delivering genes to germline or somatic cells. Yet
a LoxP based virus would probably be undesirable for
human gene therapy; even if Cre could be delivered with
virus, the delivery of multiple LoxP might create harmful
genomic deletions, inversions, and translocations. Fur-
thermore, because this application utilizes a complete ret-
rovirus, genome packaging constraints may limit the
maximum size of the transgene.Retrovirology 2004, 1 http://www.retrovirology.com/content/1/1/5
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LoxP virus as a mutator
In addition to gene delivery, the superinfecting LoxP virus
might also be useful as a mutagenesis and gene discovery
tool. Retroviruses are currently used to tag and identify
new genes of interest. The gene discovery technique relies
on the fact that the provirus is integrated into random
locations of the host genome. When by chance the provi-
rus integrates near a gene, the viral promoter and/or
enhancer may lead to over-expression of that gene. When
the provirus integrates within a gene, gene expression can
be disrupted. By screening infected cells or organisms for
the desired phenotype, the gene of interest can be identi-
fied by virtue of the proviral tag. Retroviral tagging has
been valuable in identifying developmental genes [39,40]
and oncogenes [41-44]. The superinfecting virus would be
especially useful when investigating a phenotype that
requires multiple genes. For example, tumor formation
typically requires that multiple oncogenes be activated.
Discovery of oncogenes by retroviral tagging depends on
multiple provirus integrations, which require superinfec-
tion. In principle, the LoxP virus would be able to activate
multiple oncogenes by superinfection, leading to faster
tumor formation and to a more comprehensive oncogene
discovery screen.
By delivering LoxP sites to a genome, the LoxP virus might
also serve to create large gene deletions, translocations,
and inversions. Because the superinfecting retrovirus is
Array comparative genome hybridization showing copy number changes between the mother cell line (GC4), containing Cre  recombinase, and four daughter clones infected with the LoxP virus Akv-2XY; (a) A2XYGC.2B1; (b) A2XYGC.2A2; (c)  A2XYGC.3B1; (d) A2XYGC.2C1 Figure 7
Array comparative genome hybridization showing copy number changes between the mother cell line (GC4), containing Cre 
recombinase, and four daughter clones infected with the LoxP virus Akv-2XY; (a) A2XYGC.2B1; (b) A2XYGC.2A2; (c) 
A2XYGC.3B1; (d) A2XYGC.2C1. Each cell line was analyzed twice, as conventional CGH hybridizations (left) and reverse 
array hybridizations (right) where deletions now appear as gains. Arrows indicate regions of intrachromosomal deletion. The 
cell lines may or may not have a genealogical relationship in regard to LoxP virus infection. Each black dot represents the aver-
age fluorescence ratio of 4 arrayed replicates plotted as function of their position in the genome based on Celera's assembly of 
the mouse genomic sequence; markers contained within each BAC were blasted against the genome assembly to establish the 
genomic coordinate. All data have been normalized such that the median fluorescence ratio is 0. Grey vertical bars represent 
chromosome boundaries. A two-fold reduction in fluorescence ratio (i.e. 1 versus 2 genomic copies) is represented by a value 
of -1 on this scale. Since these cell lines are aneuploid, ratios are suppressed such that single copy deletions are seen as 2 ver-
sus 3 or 3 versus 4 genomic copies.
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able to deliver numerous copies of LoxP, these mutations
can be created more proficiently. When used as a tagging
tool, the superinfecting LoxP virus would serve as a novel
mutator to identify new genes. For example, a high multi-
plicity of infection will favor the integration of two LoxP
sites (of the same directional orientation) on the same
chromosome and this would result in gene deletion.
Because large deletions of DNA (i.e. several megabases)
can occur without lethal effects [25,31,32], the superin-
fecting retrovirus could be used to tag genes where a phe-
notype results from gene inactivation. The ability to
generate large deletions would allow both alleles of a gene
to be inactivated, thus favoring the discovery of a desired
gene (e.g. a tumor suppressor gene).
Methods
Vector construction
pAkv-Y
The IRES-EYFP (Internal Ribosomal Binding Site –
Enhanced Yellow Fluorescent Protein) fragment was PCR
amplified from pIRES-EYFP (Clontech) and cloned into
the CelII site in the U3 region of the 3' LTR of pAkv [20].
Plasmid pAkv contains a partially truncated Akv provirus
and is able to produce the entire Akv retrovirus when
transfected into cells.
pAkv-2XY
By using a primer containing an overhanging LoxP
sequence, a LoxP site (ATAACTTCGTATAGCATACAT-
TATACGAAGTTAT) was added 5' to the 3' Akv LTR by PCR
amplification from pAkv. The PCR fragment was cloned
into the SfuI and SdaI sites of pAkvEn-EGFP [45], to create
pAkv-EndEnvLoxP2. This plasmid contained the Akv pro-
virus with a LoxP site between the envelope gene and the
3' LTR. Because the LoxP site of pAkv-EndEnvLoxP2 was
flanked by repetitive sequences, and because these repeti-
tive sequences might later lead to homologous recombi-
nation and subsequent deletion of the LoxP site, the
repetition in sequence was shortened by excising the PacI-
PmlI fragment of pAkv-EndEnvLoxP2, creating pAkv-
EndEnvLoxP3. By using a primer containing an overhang-
ing LoxP sequence, a LoxP site was added between the
5'LTR and gag gene by PCR amplification of the AatII-
BsiWI fragment of pAkvPro. The PCR fragment was cloned
into the AatII and BsiWI sites of pAkvEndEnvLoxP to cre-
ate pAkv-2LoxPs3. The CelII fragment containing IRES-
EYFP from pAkv-U3EYFP was cloned into the CelII site of
pAkv-2LoxPs3, creating pAkv-2LoxPs3-U3EYFP, or, for
short, pAkv-2XY (Fig. 1). (Interestingly, when a LoxP site
was added directly after the stop codon of the gene (Env-
TAA-LoxP), the engineered construct was unable to pro-
duce a functional virus. This suggests that the nucleotide
regions flanking the 3'LoxP site in Akv-2XY are important
for infection.).
Viral infection
PhoenixEco packaged viruses
Plasmids pNIT-GFP-Cre (GFP-Cre in retroviral vector NIT
[46]), pAkv-Y, and pAkv-2XY were introduced into Phoe-
nixEco cells by using Fugene transfectant (Roche Bio-
sciences). After 3 days, PhoenixEco culture supernatant
containing packaged retroviral genomes were passed
through a 0.45 µm filter, supplemented with 4 µg/ml
polybrene and added to NIH/3T3 cells. The culture
medium was replenished with fresh DMEM after 8–12 h.
The NIH/3T3 cells infected with Akv-Y and Akv-2XY were
kept in culture until all cells were infected. These cells
served to produce the viruses for the supernatant and
mixed culture infection experiments. The NIT-GFP-Cre
infected NIH/3T3 cells were isolated by fluorescence acti-
vated cell sorting (FACS) and subcloned by single-cell
sorting. The clone GC4 produced a fusion protein consist-
ing of Enhanced Green Fluorescence Protein (EGFP) and
Cre recombinase [47], and it exhibited both EGFP fluores-
cence and recombinase activity. When grown without
other cells or viruses in the same culture, GC4 demon-
strated no silencing or inactivation of fluorescence after
more than 6 months.
Infection with supernatant
Akv-Y and Akv-2XY infected NIH/3T3 were inoculated at
20–40% confluency in a 175 cm2 tissue culture flask con-
taining 40 ml of media. After 2 days, 10 ml of virus con-
taining media were passed through a 0.45 µm filter and
combined with 10 ml fresh media and 105 trypsinized
GC4 cells in an 83 cm2 flask.
Mixed culture infection
9 × 104 trypsinized GC4 cells were combined with 104
trypsinized Akv-Y or Akv-2XY infected NIH/3T3 cells.
These cells were co-cultured in an 83 cm2 flask.
Flow cytometry
The virus infection was monitored by flow cytometry.
Cells were stained with monoclonal rat antibody to viral
envelope (MAb 83A25; of IgG2A subclass) [48], and then
with allophycocyanin (APC) conjugated polyclonal goat
anti-IgG (PharMingen) as a secondary antibody. Thus, the
infected cell population was quantified by measuring APC
fluorescence of the stained cells and EYFP. GFP-Cre fluo-
rescence was also measured. GFP-Cre and EYFP could be
distinguished on a on a Becton Dickinson FACS Vantage
SE equipped with a 200 mW 488 nm laser and two band-
pass filters (510/10 nm, GFP-Cre; 550/30 nm, EYFP).
Infected cells were subcloned by single cell FACS sorting.
Provirus copy number was estimated from fluorescence
intensities by dividing the intensity of a given cell popula-
tion by a reference value of the intensity of a population
known or presumed to contain one copy of activeRetrovirology 2004, 1 http://www.retrovirology.com/content/1/1/5
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provirus per cell. The intensity of EYFP fluorescence in
NIH/3T3 infected with Akv-Y was consistently double that
of cells infected with Akv-2XY (data not shown). Appar-
ently, the EYFP expression of Akv-2XY is slightly hindered
by the two added LoxP sites. The recombined Akv-2XY
provirus showed a consistently higher (approximately
1.7×) fluorescence than the unrecombined provirus
(Table 1), suggesting that excision of the retroviral genes
augmented expression of the EYFP transgene. These differ-
ences in expression were taken into account when estimat-
ing the copy number of expressed genes. Because EYFP
fluorescence intensity might not correlate linearly with
gene expression, copy number estimations based on fluo-
rescence likely provide lower limit values. Because the
expression of an EYFP gene from a clonal population will
vary to some degree depending on its integration site, and
because different clones will have different integration
sites, the relative fluorescence intensity may be affected by
clonal variation.
Comparative Genomic Hybridization
Preparation of the BAC arrays, hybridization, and data
processing was done as described previously [33]. BAC
DNA was PCR amplified using a 5'-amine linked degener-
ate primer, printed on to amine reactive slides, and slides
were processed following manufacturer's recommenda-
tions (Motorola). Genomic DNA extracted from Akv-Y or
Akv-2XY cell lines (test sample) was labeled with Cy3 by
random primed labeling (Bioprime, Invitrogen) and
genomic DNA from GC4 cell line (reference sample) was
labeled with Cy5. Cy dyes were reversed for reverse
hybridizations. Labeled test and reference genomic DNA
samples were co-hybridized to the arrays in the presence
of excess repeat-blocking Cot-1 DNA (Invitrogen) for two
nights, washed, and imaged using a custom CCD imaging
system [49]. Image analysis was performed using custom
software [33,50]. Detailed genomic DNA extraction and
hybridization protocols are available at http://cc.ucsf.edu/
gray/public.
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